The PCAC is considering these seven peptide substances in a meeting July 23-24: BPC-157, KPV, TB-500, MOTS-C, Semax, Epitalon, Emideltide
TB-500 has also been suggested to support cystic fibrosis due to its potential impact on sputum cohesivity, which has been observed to be decreased following TB-500 exposure
Self-administering research-grade peptides without medical supervision introduces multiple layers of risk: Working with a qualified medical team eliminates these risks and ensures that your peptide therapy is aligned with your broader health and fitness goals
As a result, many laboratories rely on it for in vitro research
More serious, though rare, side effects can occur, such as symptoms of low potassium levels (muscle cramps, weakness, irregular heartbeat) or signs of an allergic reaction